知镜 Cognispect · 医学文献与研究工作台

Upper and lower airway crosstalk in acute exacerbations of COPD: a clinical and biological overview.

Ielo S, Carriera L, Mari PV, Barone R, Cefaloni F, Loperfido A, Coppola A, Baglioni S, De Corso E, Scala R.
Expert review of respiratory medicine · 2026-07-06 · PMID 42403302

文献摘要

Introduction Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are acute worsening events characterized by increased dyspnea, cough, and sputum production. Although traditionally viewed as lower airway events, growing evidence suggests that AE-COPD may reflect broader pan-airway dysfunction involving both upper and lower respiratory compartments. Areas covered This overview examines upper - lower airway crosstalk in AE-COPD across three domains: pan-airway inflammation, epithelial alarmin/cytokine networks, and the continuous airway microbiome. We discuss the coexistence of COPD with sinonasal inflammation, chronic rhinitis, and chronic rhinosinusitis, and their possible contribution to symptom burden, impaired quality of life, and exacerbation risk. We also review mechanisms linking upper and lower airways, including epithelial barrier dysfunction, impaired antiviral responses, innate immune activation, alarmin release, and microbiome-driven dysbiosis. Expert opinion Recognizing AE-COPD as a manifestation of pan-airway dysfunction may have relevant clinical implications. Systematic assessment of upper airway symptoms and comorbidities could improve phenotyping, risk stratification, and therapeutic targeting, particularly in frequent exacerbators. Future longitudinal and multi-omic studies are needed to validate upper airway biomarkers and determine whether targeted treatment of upper airway disease can modify COPD outcomes.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。